Unknown

Dataset Information

0

Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer.


ABSTRACT: Androgen receptor (AR) splice variants (SV) have been implicated in the development of metastatic castration-resistant prostate cancer and resistance to AR targeting therapies, including abiraterone and enzalutamide. Agents targeting AR-SV are urgently needed to test this hypothesis and further improve the outcome of patients suffering from this lethal disease. Clin Cancer Res; 22(17); 4280-2. ©2016 AACRSee related article by Yang et al., p. 4466.

SUBMITTER: Sharp A 

PROVIDER: S-EPMC5302169 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer.

Sharp Adam A   Welti Jonathan J   Blagg Julian J   de Bono Johann S JS  

Clinical cancer research : an official journal of the American Association for Cancer Research 20160621 17


Androgen receptor (AR) splice variants (SV) have been implicated in the development of metastatic castration-resistant prostate cancer and resistance to AR targeting therapies, including abiraterone and enzalutamide. Agents targeting AR-SV are urgently needed to test this hypothesis and further improve the outcome of patients suffering from this lethal disease. Clin Cancer Res; 22(17); 4280-2. ©2016 AACRSee related article by Yang et al., p. 4466. ...[more]

Similar Datasets

| S-EPMC6777919 | biostudies-literature
| S-EPMC4975933 | biostudies-literature
| S-EPMC3788593 | biostudies-literature
| S-EPMC9541428 | biostudies-literature
| S-EPMC5777133 | biostudies-literature
| S-EPMC4715745 | biostudies-literature
| S-EPMC3709796 | biostudies-literature
| S-EPMC7880411 | biostudies-literature
| S-EPMC4333106 | biostudies-literature
| S-EPMC4644296 | biostudies-literature